On December 29, 2017, Regeneron Pharmaceuticals (REGN) had a market capitalization of $43.5B, based on 116.2M shares at a price of $374.36.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2017 | $374.36 | 13,329,900 | 116,203,500 | $43,501,372,862.85 |
November 2017 | $360.32 | 21,696,400 | 116,203,500 | $41,869,898,963.55 |
October 2017 | $400.90 | 18,169,400 | 116,203,500 | $46,586,134,214.55 |
September 2017 | $445.21 | 16,433,500 | 117,028,000 | $52,102,199,719.20 |
August 2017 | $494.78 | 15,287,300 | 117,028,000 | $57,902,985,109.20 |
July 2017 | $489.52 | 14,085,100 | 117,028,000 | $57,287,710,399.20 |
June 2017 | $489.04 | 25,695,600 | 116,137,000 | $56,796,044,959.50 |
May 2017 | $457.10 | 20,548,900 | 116,137,000 | $53,086,269,154.80 |
April 2017 | $386.83 | 16,523,900 | 116,137,000 | $44,925,473,142.90 |
March 2017 | $385.86 | 22,474,800 | 115,245,800 | $44,468,260,355.64 |
February 2017 | $371.91 | 17,098,400 | 115,245,800 | $42,860,558,396.48 |
January 2017 | $357.76 | 21,779,200 | 115,245,800 | $41,229,910,998.54 |
December 2016 | $365.52 | 17,772,000 | 115,788,000 | $42,323,177,124.00 |
November 2016 | $377.62 | 24,676,400 | 115,788,000 | $43,723,991,926.80 |
October 2016 | $343.55 | 12,726,000 | 115,788,000 | $39,778,643,193.60 |
September 2016 | $400.30 | 16,489,500 | 116,653,700 | $46,696,931,059.43 |
August 2016 | $390.87 | 17,166,400 | 116,653,700 | $45,596,933,329.91 |
July 2016 | $423.31 | 15,297,000 | 116,653,700 | $49,380,129,474.61 |
June 2016 | $347.74 | 20,553,100 | 116,231,000 | $40,418,074,955.20 |
May 2016 | $397.23 | 20,724,600 | 116,231,000 | $46,170,103,060.10 |
April 2016 | $375.10 | 20,814,900 | 116,231,000 | $43,598,468,938.90 |
March 2016 | $358.90 | 20,597,900 | 114,228,000 | $40,996,589,119.20 |
February 2016 | $382.38 | 19,529,800 | 114,228,000 | $43,678,582,599.60 |
January 2016 | $418.30 | 21,407,200 | 114,228,000 | $47,781,206,870.40 |
December 2015 | $540.55 | 12,981,500 | 115,664,900 | $62,522,962,423.74 |
